Vince Martin

Vince Martin

Vince Martin has written investing advice for several years, covering stocks across a range of industries. A former registered representative, Martin saw the dot-com bubble inflate and burst in real time, creating a healthy respect for downside risk. He splits his time between Chicago and rural Wisconsin with his wife and three dogs.

Recent Articles

Social Ads Not the Only Risk to HEXO Stock

HEXO stock actually bottomed amid the release of a short seller's report. But investors shouldn't be so quick to dismiss it.

Ford Stock Looks Attractive On Another Pullback

Ford stock is retreating again in part due to supposedly disappointing earnings. But the numbers are better than they look - and F is too cheap.

The 10 Biggest Losers from Q2 Earnings

These 10 stocks, including UBER stock, took big hits after earnings. Some are stocks to buy for a rebound -- and some are stocks to sell.

AMD Stock’s New Products Mean Even More Market Share

As long as Advanced Micro Devices keeps outperforming Intel, the AMD stock price is going to keep moving higher.

After Earnings, TLRY Stock Remains a Strategy Play

TLRY stock is trading down after-hours following an earnings miss. But investors should focus on the longer-term strategy, which remains intriguing.

What Stops the Gains in SHOP Stock?

SHOP stock has tripled from the lows despite constant calls that it's too expensive. What can finally cause Shopify stock to stall out?

The Biggest Long-Term Question for Uber Stock

The Uber Technologies Inc business model may not be as sound as its adherents believe. Concerns about pricing and operating leverage are likely to drive the long-term performance of Uber stock.

CSX Stock Is a Good Play — But Is It the Best One?

A lower CSX stock price offsets troubling CSX news -- but the question is whether there are better opportunities for investors elsewhere.

User Numbers Dispel the Bear Case for Facebook Stock

Concern around FB stock often centers on users departing the platform. But continued user growth shows why Facebook stock is a buy.

Bristol-Myers Squibb Stock Has Upside — But Mind the Risks

Bristol-Myers Squibb stock touched a multi-year low last month. But the BMY stock price is cheap enough now to take on real risks.